Capecitabine-Induced Terminal Ileitis: Review of the Literature After a Case Report

Authors

  • Carolina Amado Serviço de Medicina Interna do Centro Hospitalar do Baixo Vouga, Aveiro, Portugal
  • Ana Rocha Oliveira Serviço de Medicina Interna do Centro Hospitalar do Baixo Vouga, Aveiro, Portugal https://orcid.org/0000-0002-7061-8127
  • Bárbara Paracana Serviço de Medicina Interna do Centro Hospitalar do Baixo Vouga, Aveiro, Portugal https://orcid.org/0009-0004-3145-9671
  • Laura Baptista Serviço de Medicina Interna do Centro Hospitalar do Baixo Vouga, Aveiro, Portugal
  • Gisela Gonçalves Serviço de Medicina Interna do Centro Hospitalar do Baixo Vouga, Aveiro, Portugal
  • Margarida Cruz Serviço de Medicina Interna do Centro Hospitalar do Baixo Vouga, Aveiro, Portugal

DOI:

https://doi.org/10.60591/crspmi.39

Keywords:

Capecitabine/adverse effects, Ileitis/chemically induced

Abstract

Capecitabine is an oral fluropyrimidine used as palliative
chemotherapy in colorectal and breast cancer patients. Diarrhea is a well-known side effect of capecitabine, being ileitis cases rare. The authors present a case of a terminal ileitis as a late iatrogenic effect of capecitabine treatment.

Downloads

Download data is not yet available.

References

Nicosia L, Russo I, De Sanctis V, Minniti G, Valeriani M, Osti MF. Two Cases of Capecitabine-Induced Ileitis in Patients Treated with Radiochemotherapy to the Pelvis and Review of the Literature. J Gastrointest Cancer. 2018;49:538-42. doi: 10.1007/s12029-017-9955-4.

Dao AE, Hsu A, Nakshabandi A, Mandaliya R, Nadella S, Sivaraman A,et al. Role of colonoscopy in diagnosis of capecitabine associated

ileitis: Two case reports. World J Gastrointest Endosc. 2019 May 16;11(5):383-388. doi: 10.4253/wjge.v11.i5.383.

Radwan R, Namelo WC, Robinson M, Brewster AE, Williams GL. Ileitis secondary to oral capecitabine treatment? Case Rep Med.

;2012:154981. doi: 10.1155/2012/154981.

van Hellemond IE, Thijs AM, Creemers GJ. Capecitabine-associated terminal ileitis. Case Rep Oncol. 2018;11:654-9. doi:

1159/000492781.

Klimko A, Tieranu CG, Olteanu AO, Preda CM, Ionescu EM. Capecitabina-induced terminal ileitis: Case report and literature review.

Cureus.2021;13:e14621. doi: 10.7759/cureus.14621.

Lam SW, Guchelaar HJ, Boven E. The role of pharmacogenetivs in capecitabine efficacy and toxicity. Cancer Treat Rev. 2016;50:9-22. doi: 10.1016/j.ctrv.2016.08.001.

Lee SF, Chiang CL, Lee AS, Wong FC, Tung SY. Severe ileitis associated with capecitabine: two case reports and review of the literature.

Mol Clin Oncol. 2015, 3:1398-400. doi: 10.3892/mco.2015.635.

Mokrim M, Aftimos PG, Errihani H, Piccart-Gebhart M. Breast cancer, DPYD mutations and capecitabine related ileitis: description

of two cases and a review of the literature. BMJ Case Rep. 2014;2014:bcr2014203647. doi: 10.1136/bcr-2014-203647.

Al-Gahmi AM, Kerr IG, Zekri JM, Zagnoon AA. Capecitabine-induced terminal ileitis. Ann Saudi Med. 2012;32:661-2. doi: 10.5144/0256-

2012.661.

European Medicines Agency. EMA recommendations on DPD testing prior to treatment with fluoracil, capecitabine, tegafur and flucytosine. EMA/229267/2020. [Jan 2023] Available from: https://www.ema.europa. eu/en/news/ema-recommendations-dpd-testing-prior-treatment-fluorouracil-capecitabine-tegafur-flucytosine

Alterações arquiteturais da mucosa ileal, com infiltrado inflamatório agudo e microabcesso central, sem evidência de microorganismos (coloração PAS).

Downloads

Published

26-02-2024

How to Cite

Amado, C., Rocha Oliveira, A., Paracana, B., Baptista, L., Gonçalves, G., & Cruz, M. (2024). Capecitabine-Induced Terminal Ileitis: Review of the Literature After a Case Report. SPMI Case Reports, 2(1), 8–12. https://doi.org/10.60591/crspmi.39

Issue

Vol. 2 No. 1 (2024): Janeiro/Março

Section

Casos Clínicos

Categories

License

Copyright (c) 2024 Carolina Amado, Ana Rocha Oliveira, Bárbara Paracana, Laura Baptista, Gisela Gonçalves, Margarida Cruz

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.